Grifols SA (GRFS) stock

GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 17, 2026Score 9/30

$8.80−0.04 (-0.45%)

Close on Nov 12, 2026Market cap $3.03BP/E 6.7Yield –

Grifols EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Grifols's EV/EBITDA was 3.8× on Nov 11, 2026, against 4.1× a year earlier. Over the last 5 years it ranged from 3.4× to 9.0×, with a median of 6.1×.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	3.8×	−0.4
2025	Dec 31, 2025	4.2×	−2.7
2024	Dec 31, 2024	6.8×	−1.0
2023	Dec 29, 2023	7.9×	+2.1
2022	Dec 30, 2022	5.8×	−0.2
2021	Dec 31, 2021	6.0×	−1.1
2020	Dec 31, 2020	7.1×	−2.5
2019	Dec 31, 2019	9.6×	+1.7
2018	Dec 31, 2018	7.9×	+2.9
2017	Dec 29, 2017	5.0×	+1.5
2016	Dec 30, 2016	3.5×	–